Sponsor:
Dana-Farber Cancer Institute
Code:
NCT06710548
Conditions
Ovarian Cancer
Advanced Ovarian Carcinoma
Fallopian Tube Carcinoma
Primary Peritoneal Cancer
PARP Inhibitor
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
REVITALIZE Intervention
Educational Materials
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Dana-Farber Cancer Institute on 2025-04-08.